Claude Ferrand

Title: Claude Ferrand: Innovator in Thieno [3,2-c] Pyridine Derivatives

Introduction

Claude Ferrand is a notable inventor based in Ramonville Saint-Agne, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on thieno [3,2-c] pyridine derivatives. His research focuses on the therapeutic applications of these compounds, which have potential benefits in medical treatments.

Latest Patents

Claude Ferrand holds a patent for "Thieno [3,2-c] pyridine derivatives and their therapeutic application." This invention pertains to new thieno [3,2-c] pyridine derivatives characterized by specific chemical formulas. These derivatives are designed to act as blood-platelet aggregation inhibiting agents and antithrombotics. The patent outlines the preparation process of these compounds and their addition salts with pharmaceutically acceptable acids and bases.

Career Highlights

Claude Ferrand is associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to explore and develop innovative therapeutic solutions that address critical health issues. With a focus on research and development, he has contributed to advancing medical science through his inventions.

Collaborations

Claude Ferrand has collaborated with esteemed colleagues, including Daniel Aubert and Jean-Pierre Maffrand. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the field of pharmaceuticals.

Conclusion

Claude Ferrand's contributions to the development of thieno [3,2-c] pyridine derivatives highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic applications that can significantly impact patient care.